| Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. | |
| | |
MedLine Citation:
|
PMID: 18627364 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Hepatic venous pressure gradient (HVPG) measurement is not a routinely used technique, despite its therapeutic and prognostic value. AIM: To review the role of HVPG from published literature. METHODS: Systematic literature review. RESULTS: In acute variceal bleeding, HVPG is prognostic identifying 'difficult to treat' group, which now has defined clinical correlations. In secondary prevention of portal hypertensive bleeding, a reduction to < or = 12 mmHg confers near complete protection against rebleeding. The target of > or = 20% HVPG reduction from baseline needs prospective assessment to test a change of therapy, if no reduction occurs. The acute HVPG response to beta-blockade needs further assessment. In primary prevention, the cost-effectiveness of HVPG measurement is not favourable given the efficacy of medical therapy. In chronic liver disease, wedge hepatic venous pressure (WHVP) is prognostic for survival. Pharmacological reduction in portal pressure decreases complications and improves survival, possibly independent of a concomitant improvement in liver function. This latter requires urgent confirmation as it is clinically very relevant. HVPG monitoring can be used to assess anti-viral therapy particularly in cirrhosis, ergonomically combined with transjugular biopsy. CONCLUSIONS: The prognostic and therapeutic value of HVPG is established beyond portal hypertensive bleeding for which there are some clinical surrogates. HVPG measurement should now be part of everyday clinical practice. |
| | |
Authors:
|
C K Triantos; V Nikolopoulou; A K Burroughs |
Related Documents
:
|
6503474 - Sorbent therapy of the porphyrias. iii. comparative efficacy of experimental plasma per... 7988184 - Intra-aortic balloon counterpulsation as a 'bridge' to cardiac transplantation. effects... 20054574 - Alterations in portal vein blood ph, hepatic functions, and hepatic histology in a porc... 6696534 - Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in pat... 3276224 - Mechanisms of altered sodium excretion after preoptic hypothalamic lesions. 21828554 - Influence of pressure on the magnetic ordering of cenisnh and cenisnh(1.8) hydrides. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Alimentary pharmacology & therapeutics Volume: 28 ISSN: 1365-2036 ISO Abbreviation: Aliment. Pharmacol. Ther. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-10-09 Completed Date: 2009-02-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8707234 Medline TA: Aliment Pharmacol Ther Country: England |
Other Details:
|
Languages: eng Pagination: 943-52 Citation Subset: IM |
Affiliation:
|
Division of Gastroenterology, Department of Internal Medicine, University Hospital, Patras, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
therapeutic use* Blood Pressure Determination / standards Hepatic Veins / drug effects, physiology* Humans Hypertension, Portal / drug therapy, physiopathology* Liver Cirrhosis / drug therapy, physiopathology* Portal Pressure / drug effects, physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary b...
Next Document: Modelling patient flows as an aid to decision making for critical care capacities and organisation.